Neuca S.A.

Neuca S.A.

NEU · WAR · Healthcare / Medical Distribution

703.00PLN+7.00 (+1.01%)

Price History

Full chart

Market Stats

Previous Close696.00
Open701.00
Day Range696.00 – 708.00
52-Week Range627.00 – 835.75
Volume1.42K
Market Cap3.22B
P/E (TTM)16.74
Forward P/E7.12
EPS42.54
Dividend Yield2.52%
Beta0.46
50-Day Avg756.68
200-Day Avg746.82

About

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Swiat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands. It also provides medical care services, including prevention, diagnostics, treatment, and complementary services; and financing services, such as insurance, subscriptions, occupational medicine, preventive and medicine programmes, FFS, NFZ, public, private, and corporate payer services. In addition, the company offers TPA services, remote consultations, in person visits, diagnostic tests, and occupational medicine services; operates a medical helpline and medical facilities; and offers medicine through apteline.pl, an e-commerce medical ordering site. Further, it engages in running clinical trials in the field of outsourcing clinical research and conducting clinical research centres; provision of insurance products, including health insurance products. Additionally, the company provides advertising and marketing services to pharmaceutical market entities; and logistics services for pharmaceutical manufacturers. The company was formerly known as Torfarm SA and changed its name to NEUCA S.A. in April 2010. NEUCA S.A. was founded in 1990 and is based in Torun, Poland.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOMr. Grzegorz Dzik
  • Employees5.00K
  • HeadquartersForteczna 35-37, Torun, Poland, 87-100, Poland
  • Websitehttps://www.neuca.pl

Leadership

  • Mr. Grzegorz DzikPresident of the Management Board
  • Mr. Krzysztof MiszewskiVice President of Management Board for Operations
  • Mr. Daniel WojtkiewiczVice President of the Management Board & Director of the Sales Division
  • Ms. Julita CzyzewskaVice President of the Management Board for the Patient Area
  • Mr. Roman DudzikVice President of the Management Board the Board of Directors for the IT Division

Financials

Income Statement

Currency: PLN2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.41B1.70B3.29B3.97B5.69B6.13B6.39B5.69B5.80B6.57B6.95B7.08B7.49B7.75B8.28B9.25B9.86B11.23B11.81B12.61B13.64B
Growth (%)-+20.22%+93.36%+20.70%+43.27%+7.81%+4.19%-10.98%+1.89%+13.35%+5.74%+1.89%+5.77%+3.58%+6.78%+11.78%+6.59%+13.87%+5.16%+6.76%+8.18%
Cost of Revenue1.32B1.58B3.08B3.67B5.25B5.62B5.84B5.12B5.24B5.98B6.27B6.36B6.75B6.97B7.44B8.27B8.84B9.99B10.51B11.17B12.09B
Gross Profit94.73M120.68M204.80M301.64M436.54M515.02M545.34M566.01M551.86M585.61M677.03M714.18M739.19M784.40M835.02M981.21M1.02B1.24B1.31B1.44B1.56B
Gross Margin6.70%7.10%6.23%7.60%7.68%8.40%8.54%9.95%9.52%8.92%9.75%10.09%9.88%10.12%10.09%10.60%10.37%11.07%11.07%11.42%11.42%
Operating Expense85.93M106.97M180.12M263.76M379.58M451.48M467.45M471.74M449.40M508.99M557.64M575.07M617.44M657.39M677.85M768.56M824.51M1.00B1.04B1.17B1.32B
Operating Income8.80M13.71M24.68M37.87M56.95M63.54M77.88M94.27M102.45M76.61M119.39M139.11M121.75M127.01M157.17M212.65M198.19M241.33M265.08M274.72M233.57M
Operating Margin0.62%0.81%0.75%0.95%1.00%1.04%1.22%1.66%1.77%1.17%1.72%1.97%1.63%1.64%1.90%2.30%2.01%2.15%2.24%2.18%1.71%
EBITDA20.09M19.95M38.51M38.03M77.29M84.79M99.67M128.45M120.16M100.39M142.92M182.47M167.14M190.32M223.61M273.79M293.42M352.41M401.82M417.85M360.38M
EBITDA Margin1.42%1.17%1.17%0.96%1.36%1.38%1.56%2.26%2.07%1.53%2.06%2.58%2.23%2.45%2.70%2.96%2.97%3.14%3.40%3.31%2.64%
Net Income10.81M11.28M16.35M14.10M36.34M37.56M53.19M66.02M85.35M93.07M101.28M111.73M94.50M98.27M117.66M141.79M150.66M137.24M146.27M154.24M155.58M
Net Income Margin0.76%0.66%0.50%0.36%0.64%0.61%0.83%1.16%1.47%1.42%1.46%1.58%1.26%1.27%1.42%1.53%1.53%1.22%1.24%1.22%1.14%
R&D----------------2.00M4.63M5.03M--
R&D as % of Total Revenue----------------0.02%0.04%0.04%--
Interest Expense3.27M3.50M9.54M18.49M20.29M26.49M30.25M24.24M14.72M16.31M13.47M12.24M11.07M15.69M12.37M14.69M12.86M51.19M84.34M73.35M63.58M
Interest Expense % of Total Revenue0.23%0.21%0.29%0.47%0.36%0.43%0.47%0.43%0.25%0.25%0.19%0.17%0.15%0.20%0.15%0.16%0.13%0.46%0.71%0.58%0.47%

Balance Sheet

Currency: PLN2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets371.26M543.57M1.14B1.35B2.03B2.08B1.97B1.87B1.92B2.57B2.68B2.69B2.91B3.12B3.41B3.61B4.12B4.84B5.18B5.51B6.33B
Total Liabilities302.11M465.11M975.66M1.18B1.80B1.84B1.68B1.53B1.51B2.10B2.15B2.10B2.26B2.46B2.77B2.83B3.23B3.91B4.12B4.10B5.06B
Total Equity69.16M78.46M160.58M168.76M204.29M233.24M279.27M336.12M405.75M457.99M517.00M578.80M645.55M653.62M644.23M766.17M847.29M880.24M990.36M1.14B1.06B
Cash5.62M7.29M12.30M10.06M22.72M12.00M10.98M17.36M4.52M32.10M72.21M68.62M29.69M32.60M78.91M22.61M64.56M208.41M105.04M109.78M137.92M
Total Debt34.15M75.67M206.14M210.53M366.23M405.57M213.09M193.73M170.53M215.60M185.71M157.00M89.53M221.56M454.25M174.92M176.59M378.08M663.43M448.57M853.32M
Net Debt28.53M68.38M193.84M200.48M343.51M393.57M202.10M176.37M166.00M183.50M113.50M88.39M59.84M188.96M375.34M152.31M112.03M169.66M558.40M338.79M715.40M

Cash Flow

Currency: PLN2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow13.20M-11.01M84.07M35.61M48.99M14.11M166.08M124.92M27.70M202.56M180.40M175.05M121.76M121.94M202.25M324.67M300.20M335.94M288.27M63.23M496.54M
Investing Cash Flow-4.18M-22.54M-175.59M3.89M-46.82M6.42M-1.25M28.16M17.16M-215.17M-48.40M-77.58M-52.66M-141.79M-135.94M-146.91M-145.49M-180.22M-257.03M-198.10M-323.45M
Financing Cash Flow-8.29M35.23M98.43M-41.75M10.49M-31.24M-165.84M-146.70M-57.69M40.19M-91.89M-101.06M-108.03M22.77M-20.00M-234.06M-112.76M-6.64M-139.09M139.62M-144.95M
Capital Expenditure14.50M4.67M7.10M18.36M25.13M12.92M19.27M15.51M22.71M36.99M31.42M44.96M58.63M110.10M121.30M85.16M52.75M81.45M94.18M92.91M124.88M
Free Cash Flow-1.30M-15.69M76.97M17.25M23.86M1.19M146.81M109.41M4.98M165.57M148.98M130.09M63.13M11.84M80.95M239.52M247.45M254.49M194.09M-29.68M371.66M
Dividends Paid2.70M2.70M4.85M5.84M7.31M8.83M10.24M11.57M14.44M17.23M19.19M22.05M26.30M29.55M32.20M37.10M44.17M51.56M58.23M66.25M72.02M
FCF to OCF-9.84%142.43%91.55%48.44%48.70%8.46%88.40%87.58%17.99%81.74%82.58%74.32%51.85%9.71%40.02%73.77%82.43%75.75%67.33%-46.94%74.85%
Dividend Paid to FCF-208.01%-17.23%6.30%33.85%30.62%739.70%6.97%10.57%289.81%10.40%12.88%16.95%41.65%249.73%39.77%15.49%17.85%20.26%30.00%-223.21%19.38%

Earnings

Report DateSep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Aug 28, 2014Nov 12, 2014Dec 31, 2014May 12, 2015Aug 27, 2015Nov 12, 2015Mar 17, 2016May 12, 2016Aug 29, 2016Nov 10, 2016Mar 16, 2017May 15, 2017Aug 29, 2017Nov 9, 2017Mar 16, 2018May 14, 2018Aug 29, 2018Nov 11, 2018Mar 22, 2019May 14, 2019Aug 27, 2019Nov 13, 2019Mar 19, 2020May 13, 2020Aug 26, 2020Nov 25, 2020Mar 24, 2021May 13, 2021Aug 26, 2021Nov 9, 2021Mar 31, 2022May 18, 2022Aug 30, 2022Nov 17, 2022Mar 28, 2023May 16, 2023Aug 30, 2023Nov 14, 2023Mar 28, 2024May 23, 2024Aug 28, 2024Nov 18, 2024Mar 27, 2025May 22, 2025Aug 28, 2025Nov 20, 2025May 20, 2026Aug 27, 2026
EPS Estimate-------------------------------------------7.5010.807.90-11.2013.80------------------
EPS Actual3.850.962.401.161.063.033.121.582.014.124.013.003.163.106.524.093.962.607.182.152.366.816.084.124.814.306.974.265.475.336.142.344.296.206.163.584.804.787.325.975.965.2910.666.699.933.8910.857.668.625.4313.018.105.643.1310.604.649.997.1712.446.709.175.6010.574.3213.165.788.75
Surprise--------------------------------------------10.80%-8.06%-50.76%--31.61%-37.54%------------------
Timing-------------------After-hoursAfter-hours-After-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-After-hoursPre-marketPre-marketAfter-hoursPre-market-After-hoursAfter-hoursAfter-hoursAfter-hours-Pre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hours-After-hoursAfter-hours-Pre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap3.22B
Enterprise Value3.41B
Trailing P/E16.74
Forward P/E7.12
Price / Sales0.23
Price / Book2.77
EPS42.54
Book Value247.69
Revenue (TTM)14.14B
Gross Profit (TTM)1.64B
EBITDA368.10M
Profit Margin1.39%
Operating Margin1.84%
Return on Equity14.97%
Return on Assets3.03%
Shares Outstanding4.52M
Shares Float1.61M
Beta0.46
Dividend Yield2.52%
Dividend Rate17.80
Payout Ratio64.30%

Dividends

20261×
17.80Jun 29, 2026
20251×
16.00Jul 15, 2025
20241×
14.50Jun 12, 2024
20231×
13.00Jul 17, 2023
20221×
11.50May 6, 2022
20211×
10.00May 10, 2021
20201×
8.65May 20, 2020
20191×
7.40May 14, 2019
20181×
6.40Jun 6, 2018
20171×
5.75May 9, 2017
20161×
5.00May 5, 2016
20151×
4.33May 20, 2015
20141×
3.80Apr 22, 2014
20131×
3.20May 9, 2013
20121×
2.60May 2, 2012
20111×
2.30Sep 26, 2011
20101×
2.00Jul 14, 2010
20091×
1.85Jul 1, 2009
20081×
1.48Jul 2, 2008
20071×
1.23Jun 12, 2007
20061×
1.00Jul 18, 2006
20051×
1.00Jun 1, 2005